Moffitt Research Identifies Crucial Biomarker for Predicting Effectiveness of KRASG12C Inhibitors in Lung Cancer Treatment
TAMPA, Fla. (Jan. 31, 2025) — In the riveting landscape of oncology, a groundbreaking study conducted by Moffitt Cancer Center ...
